| 000 | 03474nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c128029 _d128029 |
||
| 001 | 128029 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230718115608.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 200928s2020 gw | s |||| 0|eng d | ||
| 020 | _a9783319958286 | ||
| 024 | 7 |
_a10.1007/978-3-319-95828-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC845 _b2020 EB |
|
| 245 | 1 | 0 |
_aNon-Alcoholic Fatty Liver Disease : _bA 360-degree Overview _cedited by Elisabetta Bugianesi |
| 250 | _aFirst edition 2020 | ||
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing _c2020 |
|
| 300 |
_a1 recurso en línea (X, 362 páginas) _b45 ilustraciones, 41 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 | _aMedicine (SpringerNature-11650) | |
| 490 | 0 | _aMedicine (R0) (SpringerNature-43714) | |
| 505 | 0 | _aIntroduction -- Obesity and NAFLD: same problem? The burden of NAFLD worldwide -- Histo-pathology of NAFLD -- NAFLD and insulin resistance: a multisystemic -- Etiopathogenesis of NAFLD: diet, gut and NASH -- Etiopathogenesis of NAFLD: molecular mechanisms of fibrogenesis -- The natural history of NAFLD: Environmental vs Genetic Risk Factors -- NAFLD and endocrine disease: clinical implications -- NAFLD and Cardiovascular Disease: clinical implications -- NAFLD, Hepatocellular Carcinoma and extrahepatic cancers -- NAFLD in children: implications for the future -- Diagnostic algorithm for the identification of NAFLD in primary care -- Non-Invasive diagnostic approach to NASH: Biological Markers -- Non-Invasive diagnostic approach to NASH: Radiological Diagnostics -- Dietary approach to NAFLD -- Physical Activity in NAFLD: what and how much? Pharmacological Therapy of NASH -- Bariatric Surgery and NASH: a feasible option? Liver transplantation and NASH -- Unmet needs and future goals. | |
| 520 | 3 | _aThe goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) - which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia - and to share the latest information on evolving approaches to diagnosis and treatment. The book offers a comprehensive overview of the current topics of interest in the field, and provides clinical guidance on NAFLD through a multidisciplinary approach based on the latest scientific understanding of this multisystemic disease, involving the expertise of specialists including hepatologists, diabetologists, and cardiologists. The respective contributions address various aspects, including the newly released international guidelines, novel diagnostic modalities, and new experimental drugs. The work will appeal to a broad readership, from residents in internal medicine to specialists. | |
| 988 | _aSpringer_Medicine_2020 | ||
| 650 | 7 |
_2embne _9169917 _aHígado _xEnfermedades |
|
| 700 | 1 |
_aBugianesi, Elisabetta _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783319958279 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783319958293 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-95828-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_dz _b01/2021 _eIG _zSI |
||